Log In
Print this Print this

IL-1 beta antibody

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionInterleukin-1 (IL-1) beta antibody
Molecular Target Interleukin-1 (IL-1) beta
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today